Rainbow Rare Earths Phalaborwa project shaping up to be one of the lowest cost producers globally. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCATCo Regulatory News (CAT)

Share Price Information for CATCo (CAT)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 24.00
Bid: 13.00
Ask: 35.00
Change: 0.00 (0.00%)
Spread: 22.00 (169.231%)
Open: 24.00
High: 24.00
Low: 24.00
Prev. Close: 24.00
CAT Live PriceLast checked at -
CATCo Reinsurance Opportunities is an Investment Trust

To provide investors with significant capital returns and long-term distributions by making investments linked to catastrophe reinsurance risks via a variety of insurance-based investments.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Portfolio Update

8 May 2018 07:00

RNS Number : 2623N
CATCo Reinsurance Opps Fund Ltd
08 May 2018
 

FOR IMMEDIATE RELEASE

 

8 May 2018

CATCo Reinsurance Opportunities Fund Ltd. (the "Company")

Portfolio Update

 

 

To: SFS, London Stock Exchange and Bermuda Stock Exchange

 

Markel CATCo Investment Management Ltd., as Investment Manager of the Company (the "Manager"), announces its intention to increase the specific loss reserves held by the Company in relation to the Ordinary Shares for the 2017 loss events.

 

The impact of the increase is estimated to be approximately 19.5 per cent of the 31 March 2018 Ordinary Share Net Asset Value ("NAV") and will be accounted for within the 30 April 2018 NAV. On a normalised basis, this represents approximately a 14 per cent deterioration in the Ordinary Share 2017 annual performance and is equivalent to a 2017 NAV return on the Ordinary Shares of approximately -41.4 per cent (down from the -27.6 per cent reported at year-end).

 

Following the 2017 Hurricanes Harvey, Irma, Maria (HIM) and the California Wildfires, the Manager has continued to monitor the ongoing uncertainty related to these loss events.

 

Recent market information has indicated that industry loss estimates are expected to rise for Hurricane Irma following reports of significant increases in loss adjustment expenses, late claims reporting and an increase to loss exposures in the Caribbean.

 

In addition, in late April 2018, a number of reinsurance counterparties reported increases to their ultimate loss exposures related to Hurricane Irma, reinforcing the Manager's belief that industry loss estimates for this event will increase. As a result, the Manager has concluded that material increases in the 2017 specific loss reserves are required, mainly attributable to Hurricane Irma.

 

Alissa Fredricks, Chief Executive Officer, Bermuda, of Markel CATCo Investment Management Ltd. said:

 

"Following the impact of the 2017 loss events, we have maintained extensive monitoring of industry trends and the inherent uncertainty with regards to counterparty ultimate loss exposures. Until very recently, all trends were in line with expectations, providing evidence that the 2017 loss reserves would likely be sufficient to support our remaining loss exposures.

 

"However, in late April, we received updated notifications from our reinsurance counterparties indicating a material loss creep in Irma could occur. This further supports market information suggesting that abnormal levels of loss adjustment expenses and late claims have resulted in further deterioration in Irma losses, which has become the consequence of multiple catastrophic events occurring in a short period of time. 

 

"As a result of the information received in late April, we believe an increase in the Company's loss reserves is appropriate in order to mitigate any further loss creep in Irma and to reduce the Company's potential exposure to other 2017 loss events."

 

The Manager expects the next report of industry loss estimates for Hurricane Harvey and Irma will be released at the end of May 2018. The Manager continues to believe that some level of uncertainty remains with regards to the final industry insured loss impact of the 2017 loss events.

 

The Company intends to report the 30 April 2018 Net Asset Value for the Company's Ordinary Shares and C Shares in mid-May.

 

 

For further information:

Markel CATCo Investment Management Ltd.

 

Judith Wynne

General Counsel

Telephone: +1 441 493 9005

Email: judith.wynne@markelcatco.com

 

Mark Way

Chief Operating Officer

Telephone: +1 441 493 9001

Email: mark.way@markelcatco.com

Numis Securities Limited

 

David Benda / Hugh Jonathan

Telephone: +44 (0) 20 7260 1000

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
PFUBCGDUDXGBGIR
Date   Source Headline
7th Jul 20062:51 pmRNSOffer for Cambridge Antibody
3rd Jul 20064:56 pmRNSDirectorate Change
30th Jun 20064:12 pmRNSHolding(s) in Company
30th Jun 20064:06 pmRNSDelisting
30th Jun 200610:27 amRNSAdditional Listing
30th Jun 20067:02 amRNSOffer for Cambridge Antibody
27th Jun 20062:26 pmRNSHolding(s) in Company
27th Jun 200612:34 pmRNSHolding(s) in Company
23rd Jun 20062:25 pmRNSAppointment of Directors
22nd Jun 20063:07 pmRNSRule 8.3- CAT
22nd Jun 200611:31 amRNSCAT Limited appoints new CE
22nd Jun 200611:11 amRNSEPT Disclosure
22nd Jun 200611:09 amRNSEPT Disclosure
22nd Jun 20067:02 amRNSOffer for Cambridge Antibody
21st Jun 20065:11 pmRNSRule 8.1- C.A.T.
21st Jun 200611:30 amRNSEPT Disclosure
21st Jun 200610:20 amRNSEPT Disclosure
20th Jun 200610:36 amRNSEPT Disclosure
20th Jun 200610:36 amRNSEPT Disclosure
19th Jun 20063:25 pmRNSRule 8.3 - Cambridge Antibody
19th Jun 20061:07 pmRNSRule 8.3- (CAT)
19th Jun 200611:30 amRNSEPT Disclosure
19th Jun 200611:23 amRNSEPT Disclosure
19th Jun 200610:33 amRNSEPT Disclosure
16th Jun 200611:45 amRNSEPT Disclosure
16th Jun 200611:24 amRNSEPT Disclosure
16th Jun 200611:08 amRNSEPT Disclosure
15th Jun 20065:01 pmRNSEPT Disclosure
15th Jun 20062:48 pmRNSRule 8.3- (CAT)
15th Jun 20062:17 pmRNSRule 2.10 Announcement
15th Jun 200612:45 pmRNSEPT Disclosure
15th Jun 200611:36 amRNSEPT Disclosure
14th Jun 20063:38 pmRNSRule 8.3- Cambridge Antibody
14th Jun 20063:05 pmRNSRule 8.3- Cambridge Antibody
14th Jun 20061:43 pmRNSRule 8.3- (CAT)
14th Jun 200611:36 amRNSEPT Disclosure
14th Jun 200611:15 amRNSEPT Disclosure
14th Jun 200610:59 amRNSEPT Disclosure
14th Jun 200610:23 amRNSEPT Disclosure
13th Jun 20064:50 pmRNSRule 8.3- Cambridge Antibody
13th Jun 20063:54 pmRNSRule 2.10 Announcement
13th Jun 200612:18 pmRNSEPT Disclosure
13th Jun 200611:42 amRNSEPT Disclosure
13th Jun 200611:35 amRNSEPT Disclosure
13th Jun 200610:20 amRNSEPT Disclosure
12th Jun 20065:35 pmRNSRule 8.3 - Cambridge Antibody
12th Jun 200612:00 pmRNSEPT Disclosure
12th Jun 200611:34 amRNSEPT Disclosure
12th Jun 200611:14 amRNSRule 8.3- (CAT)
12th Jun 200610:08 amRNSEPT Disclosure

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.